![Cleveland Clinic Cancer Advances Podcast](/-/scassets/images/org/podcast-images/cancer-advances/cancer-advances-podcast-icon.jpg?h=3000&la=en&w=3000&hash=66B3DCCDBA34E6953B75ECD7C1A60332A4B09000)
Cancer Advances
Subscribe:
![Joel Cardenas Goicoechea, MD, MBA,](/-/scassets/images/org/podcast-images/cancer-advances/cardenas-joel.jpg?h=675&la=en&w=1200&hash=B20786938C17C3FD808ED91A654A8C778E415346)
Featured Episode
Precision in Practice: Robotic Surgery and Laparoscopic HIPEC for Ovarian Cancer
Joel Cardenas Goicoechea, MD, MBA, a Gynecologic Oncologist at Cleveland Clinic Weston Hospital in Florida, joins the Cancer Advances podcast to discuss the benefits of robotic cytoreductive surgery combined with laparoscopic HIPEC for ovarian cancer. Listen as Dr. Cardenas explains how this innovative approach offers lower complication risks, reduced blood loss, and shorter hospital stays than traditional open surgery. Tune in to learn how these advancements enhance patient outcomes and quality of life in the treatment of ovarian cancer.
Play NowAll Cancer Advances Episodes
July 18, 2024
Advancing Ovarian Cancer Treatment through Adoptive Immunotherapy
Gynecologic Oncologist, Peter Rose, MD, joins the Cancer Advances podcast to share insights on an exciting new clinical trial investigating adoptive immunotherapy for ovarian cancer. The trial investigates personalized T-cell therapies and their potential to transform treatment outcomes. Discover how this groundbreaking approach offers new hope in the battle against advanced ovarian cancer.
Play NowJuly 11, 2024
Evaluating Risk Scores for Triple-Negative Breast Cancer in Black Women
Holly Pederson, MD, an Oncologist and member of the medical breast team at Cleveland Clinic, joins the Cancer Advances podcast to discuss her research on using polygenic risk scores to predict early onset triple-negative breast cancer in Black women. While polygenic risk scores have shown promise in predicting breast cancer risk, they have mainly been tested in European women and are less accurate for other ancestries. Listen as Dr. Pederson talks about the complexities of genetic risk factors across different ancestries and how these scores can revolutionize early detection and prevention strategies.
Play NowJune 27, 2024
Oncology Pharmacovigilance Clinic
The Cancer Advances podcast is joined by Wen Wee Ma, MBBS, Director of the Novel Cancer Therapeutics Center, and Lucy Boyce Kennedy, MD, Director of the Oncology Pharmacovigilance Clinic. Listen as they discuss how this new Oncology Pharmacovigilance Clinic enhances patient care by addressing complex toxicities and side effects from immunotherapy treatment and integrates specialists from rheumatology, endocrinology, pulmonology and more.
Play NowJune 20, 2024
Non-Muscle-Invasive Bladder Cancer: Intravesical Therapy and Beyond
Nima Almassi, MD, a Urologic Oncologist at Cleveland Clinic, joins the Cancer Advances Podcast to discuss managing non-muscle-invasive bladder cancer with variant histologies. Listen as Dr. Almassi talks about effectiveness of intravesical therapy, the importance of specialized pathology reviews, and the potential need for early cystectomy in aggressive variants.
Play Now